U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07084779) titled 'Investigation of Impact of AI on Prostate Cancer Workflow' on July 17.
Brief Summary: This study will enroll participants who are undergoing an MRI before a prostate biopsy due to suspected prostate cancer. The purpose of this study is to see if the use of Artificial Intelligence (AI) helps detect lesions on an MRI better than a radiologist not using AI. The AI Rad Companion (AIRC) Prostate MRI application is a software that uses measurements of the prostate and will be utilized in this study to help detect potential cancerous lesions. The AI software will assign the lesions a PI-RADS score, which is a way to measure the chance of t...